Prelude Therapeutics Incorporated
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
1.50 |
7.00 |
8.30 |
21.70 |
37.88 |
103.48 |
| Przychód Δ r/r |
0.00% |
366.67% |
18.57% |
161.45% |
74.56% |
173.17% |
| Przychód (min) |
1.50 |
7.00 |
8.30 |
21.70 |
37.88 |
103.48 |
| Przychód (max) |
1.50 |
7.00 |
8.30 |
21.70 |
37.88 |
103.48 |
| EBITDA (średnia) |
0.90 |
4.20 |
4.98 |
13.02 |
22.73 |
62.09 |
| EBIT (średnia) |
0.90 |
4.20 |
4.98 |
13.02 |
22.73 |
62.09 |
| EBIT % |
60.00% |
60.00% |
60.00% |
60.00% |
60.00% |
60.00% |
| Zysk netto (średni) |
-135.17 |
-117.88 |
-74.24 |
-66.46 |
-94.76 |
-56.10 |
| Zysk netto % |
-9011.42% |
-1683.97% |
-894.40% |
-306.25% |
-250.15% |
-54.21% |
| EPS (średnia) |
-1.77 |
-1.55 |
-1.16 |
-0.88 |
-1.25 |
-0.74 |
| Liczba analityków (Przychody) |
2 |
2 |
3 |
2 |
1 |
1 |
| Liczba analityków (EPS) |
3 |
3 |
3 |
2 |
1 |
1 |
| symbol |
PRLD |
PRLD |
PRLD |
PRLD |
PRLD |
PRLD |